The impact of positive vas deferens in the biochemical relapse in patients with stage T3b prostate cancer submitted to radical Prostatectomy
DOI:
https://doi.org/10.34119/bjhrv6n6-427Palabras clave:
vas deferens, radical prostatectomy, biochemical relapseResumen
The study aimed to evaluate the influence of invasion of the vas deferens and seminal vesicles in patients undergoing radical prostatectomy for stage T3b tumor on biochemical recurrence.Methods: Retrospective analysis of 53 patients submitted to radical prostatectomy with anatomopathological stage T3b, at Hospital de Clínicas da Unicamp, between 1997 and 2014. After exclusion criteria were applied, statistical analysis of 32 participants separated into 2 groups, in which 20 patients (62.5 %) without involvement of the vas deferens (group 1) and 12 (37.5%) with invasion of the vas deferens (group 2). Biochemical recurrence was defined as an increase in prostate specific antigen (PSA) greater than or equal to 0.2 ng/ml after surgery. Results: Regarding the disease-free survival analysis, group 2 has a 3.05 times greater risk of having a biochemical recurrence compared to group 1 (HR 3.05, 95% CI 1.12-8.32, p=0.03), calculated by regression of Cox and Log Rank test. Conclusion: In conclusion, this study has identified an elevated risk of biochemical recurrence in patients with both ductus deferens and seminal vesicle invasion.
Citas
BERNEY, D. M. et al. International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 4: seminal vesicles and lymph nodes. Mod Pathol., v.24, n. 1, p. 39–47, 2011.
BRAND, T. C. et al. Prostate cancer detection strategies. Curr Urol Rep., v .7, n. 3, p. 181–155, 2006.
BORRE, M. et al. Survival of prostate cancer patients in central and northern Denmark, 1998-2009. Clin Epidemiol., v.3, p. 41-46, 2011.
FREEDLAND, S. J. et al. Predictors of prostate-specific antigen progression among men with seminal vesicle invasion at the time of radical prostatectomy. Cancer, v. 100, n. 8, 1633–1638, 2004.
GRÖNBERG, H. Prostate cancer epidemiology. Lancet, v. 361, n. 9360, p. 859-864, 2003.
HSING, A. CHOKKALINGAM, A. P. Prostate cancer epidemiology. Front Biosci., v. 11, p. 1388-1413, 2006.
ISHIZAKI, F. et al. Prediction of pathological and oncological outcomes based on extended prostate biopsy results in patients with prostate cancer receiving radical prostatectomy: a single institution study. Diagn Pathol., v. 7, n. 68, 2012.
JANG, W. S. et al. Prognostic Significance of Vas Deferens Invasion After Radical Prostatectomy in Patients with Pathological Stage T3b Prostate Cancer. Ann Surg Oncol., v. 24, n. 4, p.1143–1149, 2017.
KOTB, A. F.; ELABBADY, A. A. Prognostic Factors for the Development of Biochemical Recurrence after Radical Prostatectomy. Prostate Cancer, 2011.
KWAST, T. H. V. et al. International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 2: T2 substaging and prostate cancer volume. Mod Pathol., v. 24, n.1, p. 16-25, 2011.
PARKIN, D. M., BRAY, F. I.; DEVESA, S. S. Cancer burden in the year 2000. The global picture. Eur J Cancer., v. 37, suppl. 8, p. 4–66, 2001.
